J Korean Med Sci.  2006 Oct;21(5):883-890. 10.3346/jkms.2006.21.5.883.

Antibiotic Prophylaxis Using Third Generation Cephalosporins Can Reduce the Risk of Early Rebleeding in the First Acute Gastroesophageal Variceal Hemorrhage: A Prospective Randomized Study

• Jun CH
• Park CH
• Lee WS
• Joo YE
• Kim HS
• Choi SK
• Rew JS
• Kim SJ
• Kim YD

• KMID: 1781910
• DOI: http://doi.org/10.3346/jkms.2006.21.5.883

Abstract

Bacterial infection may be a critical trigger for variceal bleeding. Antibiotic prophylaxis can prevent rebleeding in patients with acute gastroesophageal variceal bleeding (GEVB). The aim of the study was to compare prophylactic third generation cephalosporins with on-demand antibiotics for the prevention of gastroesophageal variceal rebleeding. In a prospective trial, patients with the first acute GEVB were randomly assigned to receive prophylactic antibiotics (intravenous cefotaxime 2 g q 8 hr for 7 days, prophylactic antibiotics group) or to receive the same antibiotics only when infection became evident (on-demand group). Sixty-two patients in the prophylactic group and 58 patients in the on-demand group were included for analysis. Antibiotic prophylaxis decreased infection (3.2% vs. 15.5%, p=0.026). The actuarial rebleeding rate in the prophylactic group was significantly lower than that in the ondemand group (33.9% vs. 62.1%, p=0.004). The difference of rebleeding rate was mostly due to early rebleeding within 6 weeks (4.8% vs. 20.7%, p=0.012). On multivariate analysis, antibiotic prophylaxis (relative hazard: 0.248, 95% confidence interval (CI): 0.067-0.919, p=0.037) and bacterial infection (relative hazard: 3.901, 95% CI: 1.053-14.448, p=0.042) were two independent determinants of early rebleeding. In conclusion, antibiotic prophylaxis using third generation cephalosporins can prevent bacterial infection and early rebleeding in patients with the first acute GEVB.

Keyword

Esophageal and Grastric Varices; Variceal Bleeding; Liver Cirrhosis; Antibiotic Prophylaxis; Bac-terial Infections

MeSH Terms

Recurrence
Prospective Studies
Middle Aged
Male
Humans
Hemostasis
Gastrointestinal Hemorrhage/*prevention & control
Female
Esophageal and Gastric Varices/*complications/mortality
Cephalosporins/*therapeutic use
Bacterial Infections/prevention & control
*Antibiotic Prophylaxis
Aged
Adult

Figure

• 

  Fig. 1 Actuarial probability of remaining free of rebleeding in the patients in terms of prophylactic and on-demand antibiotics use. The difference between the groups was statistically significant (p=0.0035 by log-rank test).

• 

  Fig. 2 Actuarial probability of remaining free of early rebleeding in the patients in terms of prophylactic and on-demand antibiotics use. The difference between the groups was statistically significant (p=0.0085 by log-rank test).

• 

  Fig. 3 Actuarial probability of remaining free of late rebleeding in the patients in terms of prophylactic and on-demand antibiotics use. The difference between the groups was not significant (p=0.0943 by log-rank test).

• 

  Fig. 4 Actuarial probability of survival in the patients in terms of prophylactic and on-demand antibiotics use. The difference between the groups was not significant (p=0.4165 by log-rank test).

Reference

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981. 80:800–809.

2. de Franchis R, Primignani M. Why do varices bleed? Gastroenterol Clin North Am. 1992. 21:85–101.

3. D'amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003. 38:599–612.

4. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004. 40:652–659.

5. de la Peña J, Bullet E, Sanches-Hernández E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suarez C. EVL Study Group. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005. 41:572–578.

6. Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004. 39:746–753.

7. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998. 27:1207–1212.

8. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistara R, Salvagnini M, Sangiovanni A. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001. 33:41–48.

9. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M. International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut. 2005. 54:718–725.

10. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation, and variceal bleeding in cirrhosis. Gut. 2005. 54:556–563.

11. Pugh RN, Murray-Lyon IM, Dawson JL, Peitroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg. 1973. 60:646–649.

12. Bruix J, Sherman M, LIovet JM, Beaugrand M, Leincioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J. Clincal management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001. 35:421–430.

13. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. International Ascites Club. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000. 32:142–153.

14. Conn HO. Ammonia tolerance in the diagnosis of esophageal varices: A comparison of the endoscopic, radiologic, and biochemical techniques. J Lab Clin Med. 1967. 70:442–451.

15. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet. 1999. 353:139–142.

16. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 1985. 5:463–467.

17. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, Sainz S, Anguera A, Cusso X, Balanzo J. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology. 1992. 103:1267–1272.

18. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994. 20:34–38.

19. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology. 1996. 24:802–826.

20. Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, Lee SD. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol. 1998. 93:962–966.

21. Sabat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzo J, Guarner C. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding. Am J Gastroenterol. 1998. 93:2457–2462.

22. Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterol Clin North Am. 2003. 32:1079–1105.

23. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002. 35:140–148.

24. Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis. 1998. 26:1066–1070.

25. Diehl AM. Liver disease in alcohol abusers: clinical perspective. Alcohol. 2002. 27:7–11.

26. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004. 40:652–659.

27. Bernard B, Grange JD, Khac EN, Amior X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding. A meta-analysis. Hepatology. 1999. 29:1655–1661.